Difference between revisions of "Wang T, et al. Cancer Lett. (2018) cited as Ref 152 in DOI: 10.1038/s41392-020-0110-5 (Q9415)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2018, #quickstatements; #temporary_batch_1590002823654) |
(Created claim: Page(s) (P105): 11-24, #quickstatements; #temporary_batch_1590074839150) |
||
| (3 intermediate revisions by the same user not shown) | |||
| Property / Published In Name String | |||
| + | Cancer Lett. | ||
| Property / Published In Name String: Cancer Lett. / rank | |||
| + | Normal rank | ||
| Property / Volume | |||
| + | 430 | ||
| Property / Volume: 430 / rank | |||
| + | Normal rank | ||
| Property / title | |||
| + | SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance (English) | ||
| Property / title: SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance (English) / rank | |||
| + | Normal rank | ||
| Property / Page(s) | |||
| + | 11-24 | ||
| Property / Page(s): 11-24 / rank | |||
| + | Normal rank | ||
Latest revision as of 15:32, 21 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Wang T, et al. Cancer Lett. (2018) cited as Ref 152 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Wang T
0 references
2018
0 references
Cancer Lett.
0 references
430
0 references
SMYD3 controls a Wnt-responsive epigenetic switch for ASCL2 activation and cancer stem cell maintenance (English)
0 references
11-24
0 references
